News & Events

  • September 29, 2016

    BioPharma X Corporation announced the closing of their Registered Direct offering in the amount of $930,000.  EG&S acted as counsel to the Placement Agent.

  • September 28, 2016

    Apricus BioSciences Inc. announced the closing of their Registered Direct offering in the amount of $3,734,286.  EG&S acted as counsel to the Placement Agent.

  • September 21, 2016

    OurCrowd announced the closing of their Series C Offering in the amount of $71,000,000.  EG&S acted as counsel to OurCrowd.

  • September 19, 2016

    Rexahn Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000.  EG&S acted as counsel to the Placement Agent.

  • September 15, 2016

    CytoDyn, Inc. announced the closing of their Registered Direct offering in the amount of $10,000,000.  EG&S acted as counsel to the Placement Agent.

  • September 14, 2016

    Cancer Genetics, Inc. announced the closing of their Registered Direct offering in the amount of $5,500,000.  EG&S acted as counsel to the Placement Agent.

  • September 14, 2016

    Real Goods Solar, Inc. announced the closing of their Underwritten offering in the amount of $2,407,125.  EG&S acted as counsel to the Underwriter.

  • September 14, 2016

    PFO Global, Inc. announced the closing of their PIPE offering in the amount of $350,000. EG&S acted as counsel to the Investor.

  • September 12, 2016

    Medigus Ltd. announced the closing of their Registered Direct offering in the amount of $1,472,000.  EG&S acted as counsel to the Investor.

  • September 06, 2016

    Atossa Genetics Inc. announced the closing of their Underwritten offering in the amount of $2,875,000.  EG&S acted as counsel to the Underwriter.

  • September 06, 2016

    Hemispherex Biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $5,000,000.  EG&S acted as counsel to the Placement Agent.

  • August 26, 2016

    Northwest Biotherapeutics Inc. announced the closing of their PIPE offering in the amount of $1,280,000.  EG&S acted as counsel to the Placement Agent.

  • August 26, 2016

    Optex Systems Holdings, Inc. announced the closing of their Underwritten offering in the amount of $4,751,945.  EG&S acted as counsel to the Underwriter.

  • August 25, 2016

    Richard P. Kaye, a member of the Firm, was invited by the Dispute Resolution Section of The New York State Bar Association to participate in its continuing legal education program on Arbitration on October 28, 2016.  Entitled The Next Iteration of ADR - It's Not Just Alternative Anymore, Mr. Kaye will be a member of the panel for the topic "Building a Better Arbitration: Avoiding Pitfalls and Problems.”  Mr. Kaye, who leads the firm’s Litigation Practice Group, has substantial experience in Alternative Dispute Resolution (ADR) proceedings, including both Arbitration and Mediation.  The panel for this program, which consists of both practitioners and arbitrators, will share their experiences and suggestions for conducting an effective and successful arbitration hearing.

  • August 24, 2016

    EMAGIN Corp. announced the closing of their Registered Direct offering in the amount of $4,500,000.  EG&S acted as counsel to the Placement Agent.

  • August 22, 2016

    Legend Oil and Gas, Ltd. announced the closing of their PIPE offering in the amount of $350,000.  EG&S acted as counsel to the Investor.

  • August 19, 2016

    Stellar Acquisition III, a Greek blank check company, announced the closing of its initial public offering in the amount of $65,000,000.  EG&S acted as counsel to Stellar.

  • August 17, 2016

    Neonode, Inc. announced the closing of their PIPE offering in the amount of $8,600,000.  EG&S acted as counsel to the Placement Agent.

  • August 16, 2016

    PFO Global, Inc. announced the closing of their PIPE offering in the amount of $448,000.  EG&S acted as counsel to the Investor.

  • August 15, 2016

    Catasys, Inc. announced the closing of their PIPE offering in the amount of $1,500,000.  EG&S acted as counsel to the Investor.

  • August 15, 2016

    StemCells, Inc. announced the closing of their PIPE offering in the amount of $2,000,000.  EG&S acted as counsel to the Investor.

  • August 12, 2016

    Boston Therapeutics, Inc. announced the closing of their PIPE offering in the amount of $1,300,000.  EG&S acted as counsel to the placement agent.

  • August 12, 2016

    Aridis Pharmaceuticals, Inc. announced the closing of their private placement in the amount of $15,200,000.  EG&S acted as counsel to the placement agent.

  • August 11, 2016

    Check Cap Ltd. announced the closing of their Registered Direct offering in the amount of $6,000,000.  EG&S acted as counsel to the Investor.

  • August 05, 2016

    Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) announced the pricing of its Registered Direct offering in the amount of $4,900,000.  EG&S acted as counsel to the Placement Agent.